safranal has been researched along with Myocardial Ischemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, X; Guan, S; Jin, W; Wang, H; Xue, Y; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for safranal and Myocardial Ischemia
| Article | Year |
|---|---|
Safranal, an active constituent of saffron, ameliorates myocardial ischemia via reduction of oxidative stress and regulation of Ca
Topics: Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Crocus; Cyclohexenes; Disease Models, Animal; Isoproterenol; Male; Malondialdehyde; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxidative Stress; Phytotherapy; Rats, Sprague-Dawley; Superoxide Dismutase; Terpenes | 2020 |